Key Aspects of Cipla: Respiratory Leadership: Known for having the widest range of drug-device combinations for respiratory care in India and emerging markets. Strategic Units: Operates through key business units focusing on active pharmaceutical ingredients (APIs), respiratory products, and Global Access. Key Products: Produces medications like anti-depressant escitalopram oxalate, antiretrovirals (lamivudine), and respiratory treatments (fluticasone propionate). Innovation & Access: Pioneered in making HIV/AIDS treatment affordable in 2001 and continues focusing on complex therapies and patient care. Stock Information: Listed on the NSE, it is a significant pharmaceutical player, with a market capitalization often exceeding ₹97,000 Cr